GTC Biotherapeutics (fka GTCB)

[croumagnon]

"I find it odd that you assume GTC’s partners want to be in the banking business."

What other reasonable solution is there? They need a cash infusion by December at the latest; their stock is in a pitiful state for regular financing; and barring a new partnership or a takeover, both of which seem unlikely in this market, it is quite reasonable to expect the partners to chime in in order to keep GTCB afloat...